<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OL</journal-id>
<journal-title-group>
<journal-title>Oncology Letters</journal-title>
</journal-title-group>
<issn pub-type="ppub">1792-1074</issn>
<issn pub-type="epub">1792-1082</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/ol.2016.4200</article-id>
<article-id pub-id-type="publisher-id">OL-0-0-4200</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Primary kidney parenchyma squamous cell carcinoma mimicking xanthogranulomatous pyelonephritis: A case report</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>WANG</surname><given-names>ZHAO</given-names></name>
<xref rid="af1-ol-0-0-4200" ref-type="aff">1</xref>
<xref rid="af2-ol-0-0-4200" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author"><name><surname>YAN</surname><given-names>BIN</given-names></name>
<xref rid="af1-ol-0-0-4200" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>WEI</surname><given-names>YONG-BAO</given-names></name>
<xref rid="af1-ol-0-0-4200" ref-type="aff">1</xref>
<xref rid="af3-ol-0-0-4200" ref-type="aff">3</xref></contrib>
<contrib contrib-type="author"><name><surname>HU</surname><given-names>NA</given-names></name>
<xref rid="af4-ol-0-0-4200" ref-type="aff">4</xref></contrib>
<contrib contrib-type="author"><name><surname>SHEN</surname><given-names>QIN</given-names></name>
<xref rid="af5-ol-0-0-4200" ref-type="aff">5</xref></contrib>
<contrib contrib-type="author"><name><surname>LI</surname><given-names>DUO</given-names></name>
<xref rid="af6-ol-0-0-4200" ref-type="aff">6</xref></contrib>
<contrib contrib-type="author"><name><surname>YANG</surname><given-names>JIN-RUI</given-names></name>
<xref rid="af1-ol-0-0-4200" ref-type="aff">1</xref>
<xref rid="fn1-ol-0-0-4200" ref-type="author-notes">&#x002A;</xref>
<xref rid="c1-ol-0-0-4200" ref-type="corresp"/></contrib>
<contrib contrib-type="author"><name><surname>YANG</surname><given-names>XIN</given-names></name>
<xref rid="af7-ol-0-0-4200" ref-type="aff">7</xref>
<xref rid="fn1-ol-0-0-4200" ref-type="author-notes">&#x002A;</xref>
<xref rid="c2-ol-0-0-4200" ref-type="corresp"/></contrib>
</contrib-group>
<aff id="af1-ol-0-0-4200"><label>1</label>Department of Urology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P.R. China</aff>
<aff id="af2-ol-0-0-4200"><label>2</label>Department of Urology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China</aff>
<aff id="af3-ol-0-0-4200"><label>3</label>Department of Urology, Fujian Provincial Hospital, The Teaching Hospital of Fujian Medical University, Fuzhou, Fujian 350001, P.R. China</aff>
<aff id="af4-ol-0-0-4200"><label>4</label>Department of PET/CT Center, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P.R. China</aff>
<aff id="af5-ol-0-0-4200"><label>5</label>Department of Radiology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P.R. China</aff>
<aff id="af6-ol-0-0-4200"><label>6</label>Department of Pathology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P.R. China</aff>
<aff id="af7-ol-0-0-4200"><label>7</label>Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P.R. China</aff>
<author-notes>
<corresp id="c1-ol-0-0-4200"><italic>Correspondence to</italic>: Professor Jin-Rui Yang, Department of Urology, The Second Xiangya Hospital, Central South University, 139 Ren Min Road, Changsha, Hunan 410011, P.R. China, E-mail: <email>yjinrui@yahoo.com</email></corresp>
<corresp id="c2-ol-0-0-4200">Mr. Xin Yang, Department of Oncology, The Second Xiangya Hospital, Central South University, 139 Ren Min Road, Changsha, Hunan 410011, P.R. China, E-mail: <email>xinyangoncolo@163.com</email></corresp>
<fn id="fn1-ol-0-0-4200"><label>&#x002A;</label><p>Contributed equally</p></fn>
</author-notes>
<pub-date pub-type="ppub">
<month>03</month>
<year>2016</year></pub-date>
<pub-date pub-type="epub">
<day>08</day>
<month>02</month>
<year>2016</year></pub-date>
<volume>11</volume>
<issue>3</issue>
<fpage>2179</fpage>
<lpage>2181</lpage>
<history>
<date date-type="received"><day>17</day><month>12</month><year>2014</year></date>
<date date-type="accepted"><day>22</day><month>01</month><year>2016</year></date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2016, Spandidos Publications</copyright-statement>
<copyright-year>2016</copyright-year>
</permissions>
<abstract>
<p>Primary kidney parenchyma squamous cell carcinoma is extremely rare, and this is the forth case to be reported. In the present study, a case of a 61-year old man is discussed. The man presented with recurrent lumbago, gross hematuria for nearly 2 months, and suspicious inflammatory kidney diseases on contrast-enhanced computed tomography (CT) and fludeoxyglucose-positron emission tomography (FDG-PET)/CT, but a tumor can not be excluded completely prior to surgery. Finally, radical nephrectomy was performed, and histological analysis determined that the diagnosis was kidney parenchyma squamous cell carcinoma with inflammation invasion. The present case highlights the potential confusion of preoperative diagnosis of renal tumor with inflammation, and introduces the potential role of FDG-PET in its diagnosis and survival evaluation in renal malignancies.</p>
</abstract>
<kwd-group>
<kwd>kidney</kwd>
<kwd>squamous cell carcinoma</kwd>
<kwd>FDG-PET</kwd>
<kwd>malignancy</kwd>
<kwd>prognosis</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Kidney squamous cell carcinomas are rare occurrences in renal malignancies, particularly for kidney parenchyma squamous cell carcinoma (<xref rid="b1-ol-0-0-4200" ref-type="bibr">1</xref>&#x2013;<xref rid="b5-ol-0-0-4200" ref-type="bibr">5</xref>). To the best of our knowledge, only three cases of patients with kidney parenchyma cell carcinoma have been reported since December 2014 (<xref rid="b2-ol-0-0-4200" ref-type="bibr">2</xref>&#x2013;<xref rid="b5-ol-0-0-4200" ref-type="bibr">5</xref>). The three cases consisted of a 73-year old man (<xref rid="b2-ol-0-0-4200" ref-type="bibr">2</xref>), a 51-year old man (<xref rid="b5-ol-0-0-4200" ref-type="bibr">5</xref>) and a 60-year old woman (<xref rid="b4-ol-0-0-4200" ref-type="bibr">4</xref>). All the patients underwent nephrectomies. The 73-year old man was followed up 3 months after surgery, the 51-year old man was followed up 6 and 12 months after surgery and the 60-year old woman was followed up 13 months after surgery; all patients remained alive with no evidence of disease at the time of follow-up (<xref rid="b2-ol-0-0-4200" ref-type="bibr">2</xref>&#x2013;<xref rid="b5-ol-0-0-4200" ref-type="bibr">5</xref>). The present study reports a case of kidney parenchyma squamous cell carcinoma with inflammation invasion, which mimicked xanthogranulomatous pyelonephritis on radiological examination; the literature concerning kidney squamous cell carcinomas is also reviewed.</p>
</sec>
<sec sec-type="cases">
<title>Case report</title>
<p>A 61-year old man presented to the Second Xiangya Hospital (Changsha, China) in October 2014 with right lumbago and gross hematuria that had been present for nearly 2 months. The patient had right renal parenchyma lithotomy ~14 years ago. Physical examination demonstrated positive percussion pain on the right kidney region. Palpation on the kidneys did not reveal any pathological symptoms.</p>
<p>On admission, routine urine tests demonstrated that the urine was clearly positive for white blood cells (WBCs) (WBC count, 1,187.50/&#x00B5;l; normal range, 0&#x2013;25/&#x00B5;l). C-Reactive protein measured 72.20 mg/l (normal, &#x003C;8 mg/l), erythrocyte sedimentation rate was 81 mm/h (normal, &#x003C;15 mm/h), procalcitonin was 3.23 ng/ml (normal, &#x003C;0.05 ng/ml). Renal and liver function tests results were within the normal ranges. Urine cytology examination demonstrated massive epithelial cells and neutrophils without malignancies. Contrast-enhanced computed tomography (CT) was performed using a SOMATOM Sensation CT scanner (Siemens, Munich, Germany). It demonstrated enlargement of the right kidney with abnormal morphology and dilatation of the ureter, multiloculated cyst-like masses with soft tissues, and perirenal fatty space was fuzzy (<xref rid="f1-ol-0-0-4200" ref-type="fig">Fig. 1A and B</xref>). The lesions observed on the CT scan were atypical and were considered as xanthogranulomatous pyelonephritis or tuberculosis; however, the presence of a rare renal tumor could not be completely excluded. Tuberculosis tests [purified protein derivative (PPD)-immunoglobulin (Ig)M, PPD-IgG and MycoDot] were performed and were negative.</p>
<p>In total, 10 days following admission, the patient had a fever (highest temperature, 39.6&#x00B0;C) and chills, and blood rountine tests demonstrated a white blood cell count of 16.94&#x00D7;10<sup>9</sup> cells/l (normal range, 3.50&#x2013;9.50&#x00D7;10<sup>9</sup> cells/l) and a neutrophil percentage of 92.34&#x0025; (normal range, 40.00&#x2013;75.00&#x0025;). Therefore, physicians hypothesized that the patient had septicemia. Antibiotics were prescribed (latamoxef for 2 week, 1 g twice a day, intravenous combined with moxifloxacin for 5 days, 0.4 g once a day, intravenous), which were adjusted (imipenem cilastatin sodium, 0.5 g every 6 h, intravenous) according to a routine blood test (procalcitonin and C-reactive protein) and a routine urine examination, including color, glucose and protein concentration, pH and white and red blood cell count, urine culture and advice from clinical pharmacists. After septicemia was controlled in the patient, cystoscopy was performed. Fludeoxyglucose-positron emission tomography (FDG-PET; Biography mCTx; Siemens) was also performed following the administration of 9.43 mCi FDG. Cystoscopy did not reveal the presence of carcinoma in the bladder and urethra. FDG-PET showed hydronephrosis with a fuzzy perirenal fatty space, and valid FDG was taken up by cystic-solid mixed masses in the right kidney (<xref rid="f2-ol-0-0-4200" ref-type="fig">Fig. 2</xref>). The lesions were considered to be renal malignancies, but renal inflammation diseases could not be excluded completely.</p>
<p>Right radical nephrectomy was performed. Histological examination using hematoxylin and eosin staining (Sinopharm Chemical Reagent Co., Ltd., Shanghai China) on paraffin-embedded tissues under a microscope (BX51TF; Olympus Corporation, Tokyo, Japan) demonstrated moderate-differentiated squamous cell carcinoma of the renal parenchyma with a massive invasion of inflammatory cells (<xref rid="f3-ol-0-0-4200" ref-type="fig">Fig. 3A and B</xref>). The patient was discharged 10 days following surgery. Follow-up one month after surgery in December 2014 showed that the patient had no febrile, gross hematuria or abnormal abdominal signs. Written informed consent was obtained from the patient for the publication of the present study.</p>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>Kidney squamous cell carcinomas are rare renal malignancies, and are classified as renal parenchyma and pelvic squamous cell carcinomas according to where they arise. Primary kidney pelvic squamous cell carcinomas account for 0.5&#x2013;0.8&#x0025; in kidney malignancies (<xref rid="b1-ol-0-0-4200" ref-type="bibr">1</xref>). Renal parenchyma squamous cell carcinomas are extremely rare; to the best of our knowledge only 3 cases have been reported until now (<xref rid="b2-ol-0-0-4200" ref-type="bibr">2</xref>&#x2013;<xref rid="b5-ol-0-0-4200" ref-type="bibr">5</xref>).</p>
<p>Urinary calculi and chronic inflammation are some of the important factors associated with renal squamous cell carcinomas (<xref rid="b4-ol-0-0-4200" ref-type="bibr">4</xref>,<xref rid="b5-ol-0-0-4200" ref-type="bibr">5</xref>). In the present case, the patient has a history of kidney calculi for &#x003E;14 years and surgery was performed to remove the stone. The patient exhibited chronic urinary inflammation and antibiotics were intermittently prescribed. These are two predisposing factors associated with the development of squamous cell carcinomas (<xref rid="b4-ol-0-0-4200" ref-type="bibr">4</xref>&#x2013;<xref rid="b5-ol-0-0-4200" ref-type="bibr">5</xref>).</p>
<p>Ultrasound and CT are important tools to evaluate masses in renal malignancies. Xanthogranulomatous pyelonephritis, secondary malignancies should be taken into account in order to achieve a differential diagnosis for renal masses (<xref rid="b1-ol-0-0-4200" ref-type="bibr">1</xref>). In the present case, contrast-enhanced CT revealed the presence of lesions in the right kidney. According to the patient&#x0027;s history and primary blood and urine tests, xanthogranulomatous pyelonephritis was one of the most consistent diagnosis. Difficulties exist in evaluating primary renal masses and achieving differential diagnosis in radiological examinations prior to surgery due to the nonspecific features of these lesions (<xref rid="b6-ol-0-0-4200" ref-type="bibr">6</xref>).</p>
<p>FDG-PET/CT has been verified as an effective tool in diagnosis, preoperative and prognosis evaluation in renal tumors (<xref rid="b7-ol-0-0-4200" ref-type="bibr">7</xref>,<xref rid="b8-ol-0-0-4200" ref-type="bibr">8</xref>). A meta-analysis previously demonstrated that the sensitivity and specificity of FDG-PET for renal lesions are 62 and 88&#x0025;, respectively; however, sensitivity and specificity increase to 84 and 91&#x0025; for extra-renal lesions (<xref rid="b9-ol-0-0-4200" ref-type="bibr">9</xref>). FDG-PET is reportedly more consistent in detecting extra-renal lesions than renal lesions (<xref rid="b9-ol-0-0-4200" ref-type="bibr">9</xref>). In the present case, FDG-PET/CT was performed prior to surgery. Since the kidney has an abnormal structure and if invasive inflammation has occurred, it is difficult to make a definite diagnosis prior to surgery. Sometimes renal benign diseases resemble renal malignancies, such as acute pyelonephritis, xanthogranulomatous pyelonephritis or inflammatory pseudotumors on FDG-PET/CT (<xref rid="b10-ol-0-0-4200" ref-type="bibr">10</xref>&#x2013;<xref rid="b12-ol-0-0-4200" ref-type="bibr">12</xref>).</p>
<p>Maximum standardized uptake value (SUV<sub>max</sub>) in FDG-PET/CT is a potential measurement that may be used to evaluate patients&#x0027; survival in renal cell carcinoma (<xref rid="b8-ol-0-0-4200" ref-type="bibr">8</xref>). For the patient in the present case, the SUV<sub>max</sub> of the early image was 19.9, and 33.8 in the delayed image. According to Ferda <italic>et al</italic> (<xref rid="b8-ol-0-0-4200" ref-type="bibr">8</xref>) 12 month-mortality rate may be as high as 62.5&#x0025;. Follow-up for the patient is therefore extremely important.</p>
<p>Primary kidney parenchyma squamous cell carcinoma is rare. The present study introduces a case of primary kidney parenchyma squamous cell carcinoma in a 61-year old man, which was initially diagnosed as xanthogranulomatous pyelonephritis on CT. In addition, FDG-PET/CT did not distinguish renal inflammation diseases from various types of tumors in the present case. Right radical nephrectomy was performed, and histological diagnosis determined a case of kidney parenchyma squamous cell carcinoma with inflammation invasion. The 1 year mortality for this case may reach as high as 62.5&#x0025; according to the SUV<sub>max</sub>. In conclusion, FDG-PET/CT is critical in assisting with the diagnosis and prognosis evaluation in kidney malignancies.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="b1-ol-0-0-4200"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalayci</surname><given-names>OT</given-names></name><name><surname>Bozdag</surname><given-names>Z</given-names></name><name><surname>Sonmezgoz</surname><given-names>F</given-names></name><name><surname>Sahin</surname><given-names>N</given-names></name></person-group><article-title>Squamous cell carcinoma of the renal pelvis associated with kidney stones: Radiologic imaging features with gross and histopathological correlation</article-title><source>J Clin Imaging Sci</source><volume>3</volume><fpage>14</fpage><year>2013</year><pub-id pub-id-type="doi">10.4103/2156-7514.109741</pub-id><pub-id pub-id-type="pmid">23814686</pub-id></element-citation></ref>
<ref id="b2-ol-0-0-4200"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terada</surname><given-names>T</given-names></name></person-group><article-title>Synchronous squamous cell carcinoma of the kidney, squamous cell carcinoma of the ureter and sarcomatoid carcinoma of the urinary bladder: A case report</article-title><source>Pathol Res Pract</source><volume>206</volume><fpage>379</fpage><lpage>383</lpage><year>2010</year><pub-id pub-id-type="doi">10.1016/j.prp.2009.07.021</pub-id><pub-id pub-id-type="pmid">19766408</pub-id></element-citation></ref>
<ref id="b3-ol-0-0-4200"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pusiol</surname><given-names>T</given-names></name><name><surname>Zorzi</surname><given-names>MG</given-names></name><name><surname>Morini</surname><given-names>A</given-names></name></person-group><article-title>Comment on: Primary squamous cell carcinoma of the renal parenchyma</article-title><source>Indian J Pathol Microbiol</source><volume>56</volume><fpage>70</fpage><year>2013</year><pub-id pub-id-type="doi">10.4103/0377-4929.116160</pub-id><pub-id pub-id-type="pmid">23924569</pub-id></element-citation></ref>
<ref id="b4-ol-0-0-4200"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kulshreshtha</surname><given-names>P</given-names></name><name><surname>Kannan</surname><given-names>N</given-names></name><name><surname>Bhardwaj</surname><given-names>R</given-names></name><name><surname>Batra</surname><given-names>S</given-names></name></person-group><article-title>Primary squamous cell carcinoma of the renal parenchyma</article-title><source>Indian J Pathol Microbiol</source><volume>55</volume><fpage>370</fpage><lpage>371</lpage><year>2012</year><pub-id pub-id-type="doi">10.4103/0377-4929.101747</pub-id><pub-id pub-id-type="pmid">23032834</pub-id></element-citation></ref>
<ref id="b5-ol-0-0-4200"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>P</given-names></name><name><surname>Saha</surname><given-names>K</given-names></name></person-group><article-title>Primary intraparenchymal squamous cell carcinoma of the kidney: A rare and unique entity</article-title><source>Case Rep Pathol</source><volume>2014</volume><fpage>256813</fpage><year>2014</year><pub-id pub-id-type="pmid">24575308</pub-id></element-citation></ref>
<ref id="b6-ol-0-0-4200"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhaijee</surname><given-names>F</given-names></name></person-group><article-title>Squamous cell carcinoma of the renal pelvis</article-title><source>Ann Diagn Pathol</source><volume>16</volume><fpage>124</fpage><lpage>127</lpage><year>2012</year><pub-id pub-id-type="doi">10.1016/j.anndiagpath.2011.08.009</pub-id><pub-id pub-id-type="pmid">22192451</pub-id></element-citation></ref>
<ref id="b7-ol-0-0-4200"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oyama</surname><given-names>N</given-names></name><name><surname>Ito</surname><given-names>H</given-names></name><name><surname>Takahara</surname><given-names>N</given-names></name><name><surname>Miwa</surname><given-names>Y</given-names></name><name><surname>Akino</surname><given-names>H</given-names></name><name><surname>Kudo</surname><given-names>T</given-names></name><name><surname>Okazawa</surname><given-names>H</given-names></name><name><surname>Fujibayashi</surname><given-names>Y</given-names></name><name><surname>Komatsu</surname><given-names>K</given-names></name><name><surname>Tsukahara</surname><given-names>K</given-names></name><name><surname>Yokoyama</surname><given-names>O</given-names></name></person-group><article-title>Diagnosis of complex renal cystic masses and solid renal lesions using PET imaging: Comparison of 11C-acetate and 18F-FDG PET imaging</article-title><source>Clin Nucl Med</source><volume>39</volume><fpage>e208</fpage><lpage>e214</lpage><year>2014</year><pub-id pub-id-type="doi">10.1097/RLU.0000000000000287</pub-id><pub-id pub-id-type="pmid">24217534</pub-id></element-citation></ref>
<ref id="b8-ol-0-0-4200"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferda</surname><given-names>J</given-names></name><name><surname>Ferdova</surname><given-names>E</given-names></name><name><surname>Hora</surname><given-names>M</given-names></name><name><surname>Hes</surname><given-names>O</given-names></name><name><surname>Finek</surname><given-names>J</given-names></name><name><surname>Topolcan</surname><given-names>O</given-names></name><name><surname>Kreuzberg</surname><given-names>B</given-names></name></person-group><article-title>18F-FDG-PET/CT in potentially advanced renal cell carcinoma: A role in treatment decisions and prognosis estimation</article-title><source>Anticancer Res</source><volume>33</volume><fpage>2665</fpage><lpage>2672</lpage><year>2013</year><pub-id pub-id-type="pmid">23749925</pub-id></element-citation></ref>
<ref id="b9-ol-0-0-4200"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>HY</given-names></name><name><surname>Ding</surname><given-names>HJ</given-names></name><name><surname>Chen</surname><given-names>JH</given-names></name><name><surname>Chao</surname><given-names>CH</given-names></name><name><surname>Lu</surname><given-names>YY</given-names></name><name><surname>Lin</surname><given-names>WY</given-names></name><name><surname>Kao</surname><given-names>CH</given-names></name></person-group><article-title>Meta-analysis of the diagnostic performance of [18F]FDG-PET and PET/CT in renal cell carcinoma</article-title><source>Cancer Imaging</source><volume>12</volume><fpage>464</fpage><lpage>474</lpage><year>2012</year><pub-id pub-id-type="doi">10.1102/1470-7330.2012.0042</pub-id><pub-id pub-id-type="pmid">23108238</pub-id></element-citation></ref>
<ref id="b10-ol-0-0-4200"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCammack</surname><given-names>KC</given-names></name><name><surname>Hawkes</surname><given-names>NC</given-names></name><name><surname>Silverman</surname><given-names>ED</given-names></name><name><surname>Paz</surname><given-names>DA</given-names></name></person-group><article-title>PET/CT appearance of acute pyelonephritis</article-title><source>Clin Nucl Med</source><volume>38</volume><fpage>e299</fpage><lpage>e301</lpage><year>2013</year><pub-id pub-id-type="doi">10.1097/RLU.0b013e31827a218d</pub-id><pub-id pub-id-type="pmid">23531731</pub-id></element-citation></ref>
<ref id="b11-ol-0-0-4200"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>G</given-names></name><name><surname>Torigian</surname><given-names>DA</given-names></name><name><surname>Alavi</surname><given-names>A</given-names></name></person-group><article-title>FDG PET/CT and MRI findings in a patient with focal xanthogranulomatous pyelonephritis mimicking cystic renal malignancy</article-title><source>Clin Nephrol</source><volume>76</volume><fpage>484</fpage><lpage>486</lpage><year>2011</year><pub-id pub-id-type="doi">10.5414/CN106762</pub-id><pub-id pub-id-type="pmid">22105452</pub-id></element-citation></ref>
<ref id="b12-ol-0-0-4200"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>KG</given-names></name><name><surname>Park</surname><given-names>HK</given-names></name><name><surname>Song</surname><given-names>SY</given-names></name><name><surname>Kim</surname><given-names>JY</given-names></name><name><surname>Kim</surname><given-names>YH</given-names></name><name><surname>Choi</surname><given-names>YY</given-names></name><name><surname>Jang</surname><given-names>KS</given-names></name><name><surname>Park</surname><given-names>MH</given-names></name></person-group><article-title>Inflammatory pseudotumor of the kidney mimicking malignancy on 18F-FDG PET/CT in a patient with diabetes and hepatocellular carcinoma</article-title><source>Clin Nucl Med</source><volume>37</volume><fpage>699</fpage><lpage>701</lpage><year>2012</year><pub-id pub-id-type="doi">10.1097/RLU.0b013e3182443e4d</pub-id><pub-id pub-id-type="pmid">22691519</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-ol-0-0-4200" position="float">
<label>Figure 1.</label>
<caption><p>CT images of the patient. (A) Normal and (B) enhanced CT scans demonstrated the enlargement of the right kidney with abnormal morphology, multiple cyst-like masses with soft tissues and the perirenal fatty space was observed to be fuzzy. CT, computed tomography.</p></caption>
<graphic xlink:href="ol-11-03-2179-g00.tif"/>
</fig>
<fig id="f2-ol-0-0-4200" position="float">
<label>Figure 2.</label>
<caption><p>FDG-PET images. The images demonstrate hydronephrosis with fuzzy perirenal fatty space, and FDG was taken up by cystic-solid mixed masses in the right kidney. CT, computed tomography; PET, positron emission tomography; FDG, fludeoxyglucose.</p></caption>
<graphic xlink:href="ol-11-03-2179-g01.tif"/>
</fig>
<fig id="f3-ol-0-0-4200" position="float">
<label>Figure 3.</label>
<caption><p>Histological examination. Hematoxlyin and eosin staining at (A) &#x00D7;40 and (B) &#x00D7;200 magnification. A massive invasion of inflammatory cells was observed, which is a hallmark of squamous cell carcinoma of the renal parenchyma.</p></caption>
<graphic xlink:href="ol-11-03-2179-g02.tif"/>
</fig>
</floats-group>
</article>
